- Home
- LPCN vs MNDO Comparison
LPCN vs MNDO Comparison
Compare LPCN & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- MNDO
- Stock Information
- Founded
- LPCN 1997
- MNDO 1995
- Country
- LPCN United States
- MNDO Israel
- Employees
- LPCN N/A
- MNDO N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- MNDO EDP Services
- Sector
- LPCN Health Care
- MNDO Technology
- Exchange
- LPCN Nasdaq
- MNDO Nasdaq
- Market Cap
- LPCN 36.8M
- MNDO 39.7M
- IPO Year
- LPCN N/A
- MNDO 2000
- Fundamental
- Price
- LPCN $4.71
- MNDO $1.96
- Analyst Decision
- LPCN Strong Buy
- MNDO
- Analyst Count
- LPCN 1
- MNDO 0
- Target Price
- LPCN $10.00
- MNDO N/A
- AVG Volume (30 Days)
- LPCN 28.3K
- MNDO 26.2K
- Earning Date
- LPCN 11-07-2024
- MNDO 11-05-2024
- Dividend Yield
- LPCN N/A
- MNDO 12.24%
- EPS Growth
- LPCN N/A
- MNDO N/A
- EPS
- LPCN N/A
- MNDO 0.23
- Revenue
- LPCN $7,922,926.00
- MNDO $21,856,000.00
- Revenue This Year
- LPCN N/A
- MNDO N/A
- Revenue Next Year
- LPCN N/A
- MNDO N/A
- P/E Ratio
- LPCN N/A
- MNDO $8.50
- Revenue Growth
- LPCN N/A
- MNDO 2.27
- 52 Week Low
- LPCN $2.38
- MNDO $1.70
- 52 Week High
- LPCN $11.79
- MNDO $2.28
- Technical
- Relative Strength Index (RSI)
- LPCN 41.11
- MNDO 48.51
- Support Level
- LPCN $4.64
- MNDO $1.95
- Resistance Level
- LPCN $4.98
- MNDO $2.00
- Average True Range (ATR)
- LPCN 0.51
- MNDO 0.03
- MACD
- LPCN -0.12
- MNDO -0.00
- Stochastic Oscillator
- LPCN 5.12
- MNDO 55.00
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets and implements real-time and off-line convergent billing and customer care software solutions. The company derives revenue from sale of software products and services in two operating segments namely Billing and Related Services, which derives key revenue and Messaging. The Company has three product lines: Product line A- billing and customer care solutions for service providers; Product line B - call accounting and call management solutions for enterprises; and Product line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in The Americas, Europe, Asia Pacific and Africa and Israel. It earns maximum revenue from Europe.